Filed: 5/9/2023ACC: 0001766721-23-000002
📋 What this filing means
AISLING CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 16 equity positions with a total reported market value of $207.81M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
16
Positions
$207.81M
Total AUM (reported)
23.12M
Total Shares
Allocation by class
COM$180.76M87.0%
SPONSORED ADS$22.40M10.8%
COM CL A$4.22M2.0%
CL A COM$441.9K0.2%
Portfolio Concentration
Top 3$147.78M71.1%
4–10$54.75M26.3%
11–25$5.29M2.5%
Top 3 weight
71.1%
Top 10 weight
97.5%
Voting Authority Distribution
Total shares with voting rights: 23.12M
Sole
Full voting authority
23.12M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole16
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings16
Rows:
BridgeBio Pharma Inc. (BBIO)
SOLEShares6.07M
TypeSH
Market value$100.61M
48.41%
Sole
6.07M
Shared
0.00
None
0.00
Biomea Fusion Inc. (BMEA)
SOLEShares798.76K
TypeSH
Market value$24.77M
11.92%
Sole
798.76K
Shared
0.00
None
0.00
Verona Pharma plc (VRNA)
SOLEShares1.12M
TypeSH
Market value$22.40M
10.78%
Sole
1.12M
Shared
0.00
None
0.00
Syndax Pharmaceuticals, Inc. (SNDX)
SOLEShares1.02M
TypeSH
Market value$21.65M
10.42%
Sole
1.02M
Shared
0.00
None
0.00
Monte Rosa Therapeutics Inc. (GLUE)
SOLEShares1.47M
TypeSH
Market value$11.47M
5.52%
Sole
1.47M
Shared
0.00
None
0.00
Elevation Oncology Inc. (ELEV)
SOLEShares2.83M
TypeSH
Market value$5.39M
2.59%
Sole
2.83M
Shared
0.00
None
0.00
Reneo Pharmaceuticals Inc. (RPHM)
SOLEShares886.08K
TypeSH
Market value$5.30M
2.55%
Sole
886.08K
Shared
0.00
None
0.00
Nuvation Bio Inc. (NUVB)
SOLEShares2.54M
TypeSH
Market value$4.22M
2.03%
Sole
2.54M
Shared
0.00
None
0.00
Aclaris Theraputics Inc. (ACRS)
SOLEShares434.45K
TypeSH
Market value$3.51M
1.69%
Sole
434.45K
Shared
0.00
None
0.00
Poseida Therapeutics Inc. (PSTX)
SOLEShares1.04M
TypeSH
Market value$3.21M
1.55%
Sole
1.04M
Shared
0.00
None
0.00
Spruce Biosciences, Inc. (SPRB)
SOLEShares1.21M
TypeSH
Market value$2.66M
1.28%
Sole
1.21M
Shared
0.00
None
0.00
AVROBIO, Inc. (AVRO)
SOLEShares1.01M
TypeSH
Market value$1.01M
0.49%
Sole
1.01M
Shared
0.00
None
0.00
Aeglea Biotherapeutics Inc. (AGLE)
SOLEShares1.69M
TypeSH
Market value$490.4K
0.24%
Sole
1.69M
Shared
0.00
None
0.00
Viracta Therapeutics Inc. (VIRX)
SOLEShares288.57K
TypeSH
Market value$458.8K
0.22%
Sole
288.57K
Shared
0.00
None
0.00
Atreca Inc. (BCEL)
SOLEShares387.65K
TypeSH
Market value$441.9K
0.21%
Sole
387.65K
Shared
0.00
None
0.00
Marker Therapeutics, Inc. (MRKR)
SOLEShares314.29K
TypeSH
Market value$223.1K
0.11%
Sole
314.29K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BridgeBio Pharma Inc. (BBIO)SOLE | COM | 6.07M | SH | $100.61M 48.41% | 6.07M | 0.00 | 0.00 |
Biomea Fusion Inc. (BMEA)SOLE | COM | 798.76K | SH | $24.77M 11.92% | 798.76K | 0.00 | 0.00 |
Verona Pharma plc (VRNA)SOLE | SPONSORED ADS | 1.12M | SH | $22.40M 10.78% | 1.12M | 0.00 | 0.00 |
Syndax Pharmaceuticals, Inc. (SNDX)SOLE | COM | 1.02M | SH | $21.65M 10.42% | 1.02M | 0.00 | 0.00 |
Monte Rosa Therapeutics Inc. (GLUE)SOLE | COM | 1.47M | SH | $11.47M 5.52% | 1.47M | 0.00 | 0.00 |
Elevation Oncology Inc. (ELEV)SOLE | COM | 2.83M | SH | $5.39M 2.59% | 2.83M | 0.00 | 0.00 |
Reneo Pharmaceuticals Inc. (RPHM)SOLE | COM | 886.08K | SH | $5.30M 2.55% | 886.08K | 0.00 | 0.00 |
Nuvation Bio Inc. (NUVB)SOLE | COM CL A | 2.54M | SH | $4.22M 2.03% | 2.54M | 0.00 | 0.00 |
Aclaris Theraputics Inc. (ACRS)SOLE | COM | 434.45K | SH | $3.51M 1.69% | 434.45K | 0.00 | 0.00 |
Poseida Therapeutics Inc. (PSTX)SOLE | COM | 1.04M | SH | $3.21M 1.55% | 1.04M | 0.00 | 0.00 |
Spruce Biosciences, Inc. (SPRB)SOLE | COM | 1.21M | SH | $2.66M 1.28% | 1.21M | 0.00 | 0.00 |
AVROBIO, Inc. (AVRO)SOLE | COM | 1.01M | SH | $1.01M 0.49% | 1.01M | 0.00 | 0.00 |
Aeglea Biotherapeutics Inc. (AGLE)SOLE | COM | 1.69M | SH | $490.4K 0.24% | 1.69M | 0.00 | 0.00 |
Viracta Therapeutics Inc. (VIRX)SOLE | COM | 288.57K | SH | $458.8K 0.22% | 288.57K | 0.00 | 0.00 |
Atreca Inc. (BCEL)SOLE | CL A COM | 387.65K | SH | $441.9K 0.21% | 387.65K | 0.00 | 0.00 |
Marker Therapeutics, Inc. (MRKR)SOLE | COM | 314.29K | SH | $223.1K 0.11% | 314.29K | 0.00 | 0.00 |